The role of immune checkpoint molecules in cancers
Immune checkpoint molecules play a central role in regulating T cell function, maintaining immune homeostasis, and facilitating tumor immune evasion, making them critical targets in cancer immunotherapy. This review provides a comprehensive overview of the structural characteristics and signaling mechanisms of key co-inhibitory and co-stimulatory molecules, and their immunoregulatory roles in both solid tumors and hematological malignancies. Recent advances in the clinical application of immune checkpoint inhibitors, combination therapy strategies, and mechanisms of resistance are discussed. Furthermore, the importance of multi-target combinatorial approaches and personalized immune modulation is emphasized, offering valuable insights and directions for optimizing cancer immunotherapy strategies.
Authors
- Lei Zhu (ORCID: https://orcid.org/0000-0002-6916-1393)
- Mingqing Zhou (ORCID: https://orcid.org/0000-0002-2757-4536)
- Zhiyun Guo
- Hao Wang
- Junjie Xu
- Hailin Tang
- Zhaokuan Zheng
- Meilan Zhang
Institutions
- Sun Yat-sen University (CN)
- First People's Hospital of Foshan (CN)
- Panyu District Central Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-14
- DOI
- https://doi.org/10.3389/fimmu.2025.1674818
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Guangzhou Medical University